Aquestive Therapeutics, Inc. (AQST) Stock Grade

About Aquestive Therapeutics, Inc.'s fundamentals

Aquestive Therapeutics is a specialty pharmaceutical company with a market capitalization of $787.9 million that is currently unprofitable, reporting a net loss in its latest annual statement and a net margin of -188.1%. The company experienced a significant revenue contraction of 22.6% year-over-year, indicating declining sales performance. With no dividend yield and an absence of a meaningful P/E ratio due to its loss position, the company is in a pre-profitability or turnaround phase typical of smaller pharmaceutical firms focused on drug development and commercialization.